Treatment of Allergic Rhinitis in Infants and Children
Authors:
- 1 December 2009
- journal article
- Published by Springer Nature in Drugs
- Vol. 69 (18) , 2541-2576
Abstract
Allergic rhinitis (AR) affects a large percentage of paediatric patients. With the wide array of available agents, it has become a challenge to choose the most appropriate treatment for patients....Keywords
This publication has 81 references indexed in Scilit:
- Pharmacokinetics of desloratadine in children between 2 and 11 years of ageBritish Journal of Clinical Pharmacology, 2007
- Desloratadine dose selection in children aged 6 months to 2 years: comparison of population pharmacokinetics between children and adultsBritish Journal of Clinical Pharmacology, 2007
- Selecting the Optimal Oral Antihistamine for Patients with Allergic RhinitisDrugs, 2006
- Economic impact and quality-of-life burden of allergic rhinitisCurrent Medical Research and Opinion, 2004
- Safety of fexofenadine in children treated for seasonal allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2001
- Montelukast Dose Selection in 6‐ to 14‐Year‐Olds: Comparison of Single‐Dose Pharmacokinetics in Children and AdultsThe Journal of Clinical Pharmacology, 1999
- PHARMACOKINETICS OF LORATADINE IN PEDIATRIC SUBJECTSAmerican Journal of Therapeutics, 1995
- H1-Receptor AntagonistsDrug Safety, 1994
- Cardiotoxic effects of astemizole overdose in childrenThe Journal of Pediatrics, 1992
- Massive diphenhydramine overdose resulting in deathAnnals of Emergency Medicine, 1982